CORRESP 1 filename1.htm

Jupiter Neurosciences, Inc.

1001 North US HWY 1, Suite 504

Jupiter, Florida 33477

September 13, 2022

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

	Re:	Jupiter Neurosciences, Inc.
		Registration Statement on Form S-1
		CIK No. 0001679628
		File No. 333-260183

Ladies and Gentlemen:

Reference is made to our letter filed as correspondence via EDGAR on September 12, 2022, in which we requested the acceleration of the effective date of the above-captioned Registration Statement for September 14, 2022, at 4:00 p.m. Eastern Time, in accordance with Rule 461 of the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date. We will notify you once we are prepared to request acceleration of the effective date of the above-captioned Registration Statement.

* * * *

Very Truly Yours,

Jupiter Neurosciences, Inc.

/s/ Christer Rosén

Christer Rosén

Chief Executive Officer